Evaluation of MAPK and PI3K/AKT Signaling Pathways In Adult Acute Lymphoblastic Leukemia

被引:0
|
作者
Loureiro, Gustavo [1 ]
Kerbauy, Daniella Bahia [1 ]
Chauffaille, Maria de Lourdes L. F. [1 ]
Lee, Maria Lucia M. [1 ]
Candido, Franciele B. M. [1 ]
Silva, Marcal C. A. [1 ]
Kimura, Eliza Y. S. [1 ]
Guirao, Fabio P. [1 ]
Rezende, Denise C. [1 ]
Yamamoto, Mihoko [1 ]
机构
[1] Univ Fed Sao Paulo, Inst Oncol Pediat, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1329 / 1329
页数:1
相关论文
共 50 条
  • [31] Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
    Patricia K. Grüninger
    Franziska Uhl
    Heike Herzog
    Gaia Gentile
    Marta Andrade-Martinez
    Tobias Schmidt
    Kyuho Han
    David W. Morgens
    Michael C. Bassik
    Michael L. Cleary
    Oliver Gorka
    Robert Zeiser
    Olaf Groß
    Jesús Duque-Afonso
    Cancer Gene Therapy, 2022, 29 : 1751 - 1760
  • [32] PI3K and MEK Inhibition in Hypodiploid Acute Lymphoblastic Leukemia
    Comeaux, Evan
    Lin, Wenwei
    Chen, Taosheng
    Freeman, Burgess, III
    Mullighan, Charles G.
    BLOOD, 2016, 128 (22)
  • [33] Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway
    Annalisa Lonetti
    Alessandra Cappellini
    Alice Bertaina
    Franco Locatelli
    Andrea Pession
    Francesca Buontempo
    Camilla Evangelisti
    Cecilia Evangelisti
    Ester Orsini
    Laura Zambonin
    Luca Maria Neri
    Alberto Maria Martelli
    Francesca Chiarini
    Journal of Hematology & Oncology, 9
  • [34] PI3K/Akt Signaling Interacts With Wnt/β-Catenin Signaling But Does Not Induce An Accumulation of β-Catenin In The Nucleus Of Acute Lymphoblastic Leukemia Cell Lines
    Langhammer, Tina-Susann
    Roolf, Catrin
    Krohn, Saskia
    Kretzschmar, Christin
    Huebner, Rayk
    Rolfs, Arndt
    Freund, Mathias
    Junghanss, Christian
    BLOOD, 2013, 122 (21)
  • [35] Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways
    Kandil, Emad
    Tsumagari, Koji
    Ma, Jingjing
    Elmageed, Zakaria Y. Abd
    Li, Xinying
    Slakey, Douglas
    Mondal, Debasis
    Abdel-Mageed, Asim B.
    JOURNAL OF SURGICAL RESEARCH, 2013, 184 (02) : 898 - 906
  • [36] Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis
    Cakir, Mehtap
    Grossman, Ashley B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (09) : 1121 - 1134
  • [37] The activity of the MAPK and PI3K/AKT/mTOR pathways are decreased in patients with achalasia
    Kipcak, S.
    Ergun, P.
    Gunel, N. Selvi
    Bor, S.
    FEBS OPEN BIO, 2022, 12 : 205 - 205
  • [38] Withanolide Metabolites Inhibit PI3K/AKT and MAPK Pro-Survival Pathways and Induce Apoptosis in Acute Myeloid Leukemia Cells
    Akhtar, Nosheen
    Baig, Muhammad Waleed
    Haq, Ihsan-ul
    Rajeeve, Vinothini
    Cutillas, Pedro Rodriguez
    BIOMEDICINES, 2020, 8 (09)
  • [39] Effects of aspirin on the ERK and PI3K/Akt signaling pathways in rats with acute pulmonary embolism
    Wang, Lingcong
    Wu, Jiannong
    Zhang, Wei
    Zhi, Yihui
    Wu, Yanchun
    Jiang, Ronglin
    Yang, Ruhui
    MOLECULAR MEDICINE REPORTS, 2013, 8 (05) : 1465 - 1471
  • [40] PI3K/Akt signaling in osteosarcoma
    Zhang, Jian
    Yu, Xiao-Hua
    Yan, Yi-Guo
    Wang, Cheng
    Wang, Wen-Jun
    CLINICA CHIMICA ACTA, 2015, 444 : 182 - 192